Clinical trial data and emerging immunotherapeutic strategies: hormone receptor-positive, HER2− negative breast cancer Matthew R. KearneyJulia E. McGuinnessKevin Kalinsky Review 02 July 2021 Pages: 1 - 13
A clinical calculator to predict disease outcomes in women with hormone receptor-positive advanced breast cancer treated with first-line endocrine therapy Mei-Yin C. PolleyMaura N. DicklerMiguel Martin Review 03 July 2021 Pages: 15 - 23
ZEB2 regulates endocrine therapy sensitivity and metastasis in luminal a breast cancer cells through a non-canonical mechanism Hope E. BurksMargarite D. MatossianMatthew E. Burow Preclinical study 06 July 2021 Pages: 25 - 37
Breast Cancer, Diabetes Mellitus and Glucagon-Like Peptide-1 Receptor Toward Exploring Their Possible Associations Naoko Hashimoto TakigamiShimpei KuniyoshiHironobu Sasano Preclinical study 02 July 2021 Pages: 39 - 48
NEK5 activity regulates the mesenchymal and migratory phenotype in breast cancer cells Margarite D. MatossianSteven ElliottMatthew E. Burow Preclinical Study 01 July 2021 Pages: 49 - 61
Heterotypic clustering of circulating tumor cells and circulating cancer-associated fibroblasts facilitates breast cancer metastasis Utsav SharmaKelsie Medina-SaenzDorraya El-Ashry Preclinical study 03 July 2021 Pages: 63 - 80
Improving the delivery of team-based survivorship care after primary breast cancer treatment through a multi-level intervention: a pilot randomized controlled trial Lauren P. WallnerPaul AbrahamseSarah T. Hawley Clinical trial 07 July 2021 Pages: 81 - 92
Neoadjuvant weekly paclitaxel and carboplatin with trastuzumab and pertuzumab in HER2-positive breast cancer: a Brown University Oncology Research Group (BrUOG) study M. L. LoprestiJ. J. BianW. M. Sikov Clinical trial 04 June 2021 Pages: 93 - 101
Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial) Kathryn J. RuddyYue ZhengSara M. Tolaney Clinical trial 12 June 2021 Pages: 103 - 110
The effect of omitting axillary dissection and the impact of radiotherapy on patients with breast cancer sentinel node macrometastases: a cohort study following the ACOSOG Z0011 and AMAROS trials Carlos Ortega ExpósitoCatalina FaloAmparo García Tejedor Clinical trial 04 June 2021 Pages: 111 - 120
Early reflector localization improves the accuracy of localization and excision of a previously positive axillary lymph node following neoadjuvant chemotherapy in patients with breast cancer Tara M. BalijaDevin BrazLeslie L. Montgomery Clinical trial 23 June 2021 Pages: 121 - 130
Predicting pathological axillary lymph node status with ultrasound following neoadjuvant therapy for breast cancer Ida SkarpingDaniel FörnvikLisa Rydén Clinical trial Open access 12 June 2021 Pages: 131 - 144
A randomized trial of exercise and diet on body composition in survivors of breast cancer with overweight or obesity Justin C. BrownDavid B. SarwerKathryn H. Schmitz Clinical trial 05 June 2021 Pages: 145 - 154
National trends for axillary lymph node dissection and survival outcomes for clinical T3/T4 node-negative breast cancer patients undergoing mastectomy with positive lymph nodes Chantal ReynaMichael E. JohnstonJaime D. Lewis Clinical trial 18 June 2021 Pages: 155 - 166
Dynamics of circulating tumor DNA during postoperative radiotherapy in patients with residual triple-negative breast cancer following neoadjuvant chemotherapy: a prospective observational study Haeyoung KimYeon Jeong KimNalee Kim Clinical trial 21 June 2021 Pages: 167 - 175
Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancer Matthew KearneyLauren FranksKevin Kalinsky Clinical trial 24 June 2021 Pages: 177 - 185
Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancer Foluso O. AdemuyiwaIna ChenMalachi Griffith Clinical trial 26 June 2021 Pages: 187 - 202
Factors associated with late risks of breast cancer-specific mortality in the SEER registry José P. LeoneCarlos T. VallejoNancy U. Lin Epidemiology Open access 24 April 2021 Pages: 203 - 212
Pathologic response of ductal carcinoma in situ to neoadjuvant systemic treatment in HER2-positive breast cancer Emma J. GroenMarieke E. M. van der NoordaaJelle Wesseling Epidemiology Open access 04 May 2021 Pages: 213 - 224
Leptomeningeal Metastasis in ER + HER2- Advanced Breast Cancer Patients: A Review of the Cases in a Single Institute Over a 15-year Period Junichiro WatanabeKoichi MitsuyaYoko Nakasu Epidemiology 08 May 2021 Pages: 225 - 236
Impact of the COVID-19 pandemic on breast cancer screening volumes and patient screening behaviors Matthew M. MillerMax O. MeneveauShayna L. Showalter Epidemiology 25 May 2021 Pages: 237 - 246
Physical activity, ethnicity, and quality of life among breast cancer survivors and population-based controls: the long-term quality of life follow-up study Kate E. DibbleRichard N. BaumgartnerAvonne E. Connor Epidemiology 29 May 2021 Pages: 247 - 256
Fat-enlarged axillary lymph nodes are associated with node-positive breast cancer in obese patients Roberta M. diFlorio-AlexanderQingyuan SongSaeed Hassanpour Epidemiology Open access 03 June 2021 Pages: 257 - 267
Pregnancy-associated breast cancer: evaluating maternal and foetal outcomes. A national study Lisa PriorRichard O’DwyerJanice M. Walshe Epidemiology 14 June 2021 Pages: 269 - 283
Impact of HIV infection on overall survival among women with stage IV breast cancer in South Africa Yoanna S. PumpalovaOluwatosin A. AyeniAlfred I. Neugut Epidemiology 14 June 2021 Pages: 285 - 296
Diffuse optical tomography breast imaging measurements are modifiable with pre-surgical targeted and endocrine therapies among women with early stage breast cancer Julia E. McGuinnessMirella L. AltoeKevin Kalinsky Brief Communication 02 July 2021 Pages: 297 - 304
Correction to: Factors associated with late risks of breast cancer‑specific mortality in the SEER registry José P. LeoneCarlos T. VallejoNancy U. Lin Correction Open access 06 July 2021 Pages: 305 - 305
